MyCelx Technologies (GB:MYX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MyCelx Technologies Corporation reported its H1 2024 financial results, highlighting the sale of its Saudi Arabian operations for $3.125 million, a gross profit margin of 28.2%, and a net loss of $1.4 million. The company has seen significant operational advancements, notably in its PFAS and REGEN media technologies, securing various contracts and trials, which forecasts a promising outlook into 2025. Additionally, MyCelx successfully raised approximately $0.9 million in equity to further its trials and potentially secure more contracts in the growing PFAS remediation and EOR markets.
For further insights into GB:MYX stock, check out TipRanks’ Stock Analysis page.